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The Authors Reply: We appreciate the interest of Tanemoto
et al.1 in our work.2 They suggest that, in the setting of
adrenalectomy, aldosterone produced locally by the kidney
could still have increased the abundance and phosphoryla-
tion of the sodium chloride cotransporter. They refer to the
work by Xue and Siragy,3 who measured renal aldosterone
levels of B15,000 pg/g versus aldosterone levels in blood
plasma and renal interstitial fluid of B700 and B15 pg/ml,
respectively. This implies that 499% of renal aldosterone is
located intracellularly. The half-life of such intracellular
aldosterone is unknown, and thus, future studies should
exclude that this represents internalized, adrenal-derived
aldosterone. Indeed, the heart is another location where,
despite initial reports on local aldosterone synthesis,
eventually it was concluded that this does not occur.4
Remarkably in this regard, Xue and Siragy localize aldoster-
one synthase in glomerular nucleoli, that is, outside its usual
site of action, the mitochondria. Moreover, when we
compared plasma and urinary aldosterone levels in 95
diabetic and/or hypertensive patients, we found that both
levels correlated closely (Figure 1; van den Heuvel and
Danser, unpublished observations). Had the kidney been an
important site of aldosterone production, resulting in the
overflow of renal aldosterone in urine, no such correlation
would have been present. We are also not aware of data
showing release of aldosterone into blood from renal tissue
sites. Clearly, more work is needed to support renal
aldosterone synthesis. Finally, experiments with aldo-
sterone synthase inhibitors or mineralocorticoid receptor
antagonists will not necessarily solve this issue, because
glucocorticoids may also activate the mineralocorticoid
receptor. Moreover, aldosterone still activated the epithelial
sodium channel in the presence of spironolactone.5
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Figure 1 |Correlation between urine and plasma aldosterone
levels in 95 diabetic and/or hypertensive patients (van den
Heuvel and Danser, unpublished observations).
1382 Kidney International (2011) 79, 1379–1382
l e t te r to the ed i to r
